摘要来源: j Pediatr胃肠道Nutr。 2022年8月1日; 75(2):215-220。 EPUB 2022 6月6日。PMID: 356666856 35666856
the
摘要:
目标:
RESULTS: Comparing the GMF to the CMF group, weight gain [mean difference 227.8 g (95% CI -16.6 to在干预112天后,用于人体测量值的-439.0)和z得分相似。婴儿配方组显示出比z得分更大的平均值(SD)体重。BF组从84天开始(GMF:0.28(0.84),CMF:0.12(0.88),BF -0.19(1.02),P <0.05),而长度和头圆周z得分相似。 Incidences of serious adverse events and reflux, fussiness, colic, and flatulence were similar among the three groups.
CONCLUSION: Our data demonstrate that GMF provides adequate growth, has a good tolerability, and is safe to use in infants.